Literature DB >> 7402361

Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.

T Alander, N E Andén, M Grabowska-Andén.   

Abstract

1. The effects of sulpiride and metoclopramide on pre- and postsynaptic dopamine receptors were investigated in the rat brain as antagonism of the apomorphine-induced inhibition of the dopamine synthesis in the absence of nerve impulses and as blockade of the apomorphine-induced rotation following unilateral inactivation of the corpus striatum, respectively. Sulpiride was more potent in blocking post- than presynaptic dopamine receptors whereas the reverse was found for metoclopramide. 2. The synthesis and the utilization of dopamine was stimulated by sulpiride and metoclopramide and was inhibited by atropine, prazosin and aminooxyacetic acid. The inhibitory effects of the latter three drugs were counteracted by metoclopramide, but not by sulpiride. This difference can be explained by the preferential action of metoclopramide on presynaptic dopamine receptors. 3. Following unilateral inactivation of the corpus striatum, metoclopramide at a low dose, but not sulpiride turned the rats ipsilaterally, indicating that the release of dopamine was facilitated and that the presynaptic dopamine receptors are of physiological significance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7402361     DOI: 10.1007/bf00569723

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  AN IMPROVED METHOD FOR FLUORIMETRIC DETERMINATION OF SMALL AMOUNTS OF ADRENALINE AND NORADRENALINE IN PLASMA AND TISSUES.

Authors:  J HAEGGENDAL
Journal:  Acta Physiol Scand       Date:  1963-11

2.  The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique.

Authors:  B S Bunney; G K Aghajanian
Journal:  Brain Res       Date:  1976-12-03       Impact factor: 3.252

3.  Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs.

Authors:  P N Elliott; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

Review 4.  A systematic study of the pharmacological activities of dopamine antagonists.

Authors:  C J Niemegeers; P A Janssen
Journal:  Life Sci       Date:  1979-06-11       Impact factor: 5.037

5.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

7.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

8.  Functional role of the nigro-neostriatal dopamine neurons.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

9.  [Clinical and electroencephalographic effects of methoclopramide in psychiatry].

Authors:  P Borenstein; G Bles
Journal:  Therapie       Date:  1965 Jul-Aug       Impact factor: 2.070

10.  Central effects of an inhibitor of tyrosine hydroxylation.

Authors:  H Corrodi; L C Hanson
Journal:  Psychopharmacologia       Date:  1966
View more
  10 in total

1.  Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

Authors:  P C Waldmeier; R Ortmann; S Bischoff
Journal:  Experientia       Date:  1982-10-15

2.  Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.

Authors:  M B Bowers; F J Hoffman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.

Authors:  A H Tissari; L Atzori; M T Galdieri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

4.  Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.

Authors:  J Grenhoff; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

5.  Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.

Authors:  K Moriuchi; Y Imazu; H Yoneda
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

6.  Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.

Authors:  Y Imazu; K Kobayashi; T Shohmori
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

Review 7.  Survey on the pharmacodynamics of the new antipsychotic risperidone.

Authors:  A A Megens; F H Awouters; A Schotte; T F Meert; C Dugovic; C J Niemegeers; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

Authors:  J E Leysen; P M Janssen; A Schotte; W H Luyten; A A Megens
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.

Authors:  K J Frantz; C Van Hartesveldt
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

10.  Trial of oral metoclopramide on diurnal bruxism of brain injury.

Authors:  Ho Sung Yi; Hyoung Seop Kim; Mi Ri Seo
Journal:  Ann Rehabil Med       Date:  2013-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.